HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats.

AbstractOBJECT:
Fetal tissue transplantation for Parkinson disease (PD) has demonstrated promising results in experimental and clinical studies. However, the widespread clinical application of this therapeutic approach is limited by a lack of fetal tissue. Human neural precursor cells (HNPCs) are attractive candidates for transplantation because of their long-term proliferation activity. Furthermore, these cells can be reproducibly expanded in a standardized fashion in suspension bioreactors. In this study the authors sought to determine whether the survival, differentiation, and migration of HNPCs after transplantation depended on the region of precursor cell origin, intracerebral site of transplantation, and duration of their expansion.
METHODS:
Human neural precursor cells were isolated from the telencephalon, brainstem, ventral mesencephalon, and spinal cord of human fetuses 8-10 weeks of gestational age, and their differentiation potential characterized in vitro. After expansion in suspension bioreactors, the HNPCs were transplanted into the striatum and substantia nigra of parkinsonian rats. Histological analyses were performed 7 weeks posttransplantation.
RESULTS:
The HNPCs isolated from various regions of the neuraxis demonstrated diverse propensities to differentiate into astrocytes and neurons and could all successfully expand under standardized conditions in suspension bioreactors. At 7 weeks posttransplantation, survival and migration were significantly greater for HNPCs obtained from the more rostral brain regions. The HNPCs differentiated predominantly into astrocytes after transplantation into the striatum or substantia nigra regions, and thus no behavioral improvement was observed.
CONCLUSIONS:
Understanding the regional differences in HNPC properties is prerequisite to their application for PD cell restoration strategies.
AuthorsKarim Mukhida, Behnam A Baghbaderani, Murray Hong, Matthew Lewington, Timothy Phillips, Marcus McLeod, Arindom Sen, Leo A Behie, Ivar Mendez
JournalNeurosurgical focus (Neurosurg Focus) Vol. 24 Issue 3-4 Pg. E8 ( 2008) ISSN: 1092-0684 [Electronic] United States
PMID18341411 (Publication Type: Journal Article)
Chemical References
  • Central Nervous System Stimulants
  • Amphetamine
Topics
  • Amphetamine (pharmacology)
  • Animals
  • Behavior, Animal (drug effects)
  • Bioreactors
  • Cell Differentiation (physiology)
  • Cell Movement (physiology)
  • Cell Survival
  • Central Nervous System (cytology, embryology)
  • Central Nervous System Stimulants
  • Disease Models, Animal
  • Embryonic Stem Cells (physiology)
  • Female
  • Fetus
  • Humans
  • Neurons (physiology)
  • Parkinson Disease (etiology, pathology, physiopathology, therapy)
  • Rats
  • Rats, Wistar
  • Stem Cell Transplantation (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: